Diabetes is one of the major degenerative disorders driven by chronic, “silent” inflammation.
Omega-3s help moderate and resolve inflammation, so it’s been presumed that diets rich in these fatty acids should help prevent or dampen diabetes – especially the majority of cases caused in part by carrying excess pounds – and substantial evidence supports that idea.
As the authors of a recent evidence review wrote, “Obesity is associated with low-grade chronic inflammation … the key link between obesity and development of insulin resistance … [Omega-3s] may therefore offer a useful anti-inflammatory strategy to decrease obesity-induced insulin resistance” (Oliver E et al. 2010).
Conversely, the omega-6 fatty acids that predominate in most vegetable oils and prepared/packaged foods – therefore in most Americans’ diets – tend to promote or sustain inflammation.
(The main exceptions are olive, macadamia, canola, and hi-oleic sunflower oils, which are relatively low in omega-6 fats.)
And it’s becoming clear that diabetes is one of the disabling diseases promoted by America’s grossly excessive intake of omega-6s.
A number of population studies have looked for links between intake of omega-3s and risk of diabetes.
Some epidemiological (population) studies link diets rich in fish and/or their omega-3s to a modestly reduced risk of diabetes… but others have found no drop or a slight rise in risk. For example, see “Diabetes-Fish Study Raises Doubts.”
Why would omega-3s help?
In addition to their anti-inflammatory influences, studies involving healthy and diabetic animals and people show that omega-3s exert beneficial metabolic effects.
These metabolic benefits include improved blood fat and inflammation profiles – which promote and sustain diabetes – in healthy and diabetic people alike.
Surprisingly, only a minority of the studies that have looked at omega-3s’ potential to deter “insulin resistance” – a primary promoter of and integral part of diabetes – indicate that fish fats help.
For more on the entire topic, see the “Omega-3s & Metabolic Health” section of our news archive.
Encouragingly, two recent studies – from the U.S. and Singapore – lent support to the hope that omega-3-rich diets can help deter diabetes (see “Omega-3s Linked to Lower Diabetes Risk”).
Now, the results of a joint U.S-Chinese epidemiological (diet-health) study conducted in Shanghai add more evidence to the positive side of the scale … especially for women.
Unusually, new study looked at all kinds of omega-3s
As in the Singapore-based study we summarized last month, the team behind the Shanghai study looked for links between diabetes rates and intake of the two major kinds of omega-3s: seafood-source and plant-source.
Most studies have only looked at the long-chain, seafood-source or “marine” omega-3s our bodies actually need to survive and thrive, called DHA and EPA.
When necessary – in the absence of seafood and fish or krill oil supplements – the body can make DHA and EPA, very inefficiently, from the short-chain, plant-source “green” omega-3 called ALA.
Omega-3 ALA – obtained by Americans from canola oil, beans, dark leafy greens (e.g., spinach and chard), flaxseed, and walnuts – has been studied less much in relation to diabetes.
The Singapore-based study we reported on last month linked higher intakes of plant-derived omega-3 ALA to a 21 percent reduction in the risk of diabetes … finding no links between higher intakes of seafood-source omega-3s and either a higher or lower risk of diabetes.
The new Shanghai study also examined peoples’ reported intake of all omega-3s – ALA from plant foods and DHA/EPA from seafood – as separate and joint influences on the risk of developing diabetes over several years.
But this time, all omega-3s came out winners … within the known limitations of epidemiological studies that rely on people’s diet recollections, and do not measure people’s omega-3 blood levels.
Remember that in the Harvard study we reported last month, which used blood tests, high levels of seafood-source omega-3s and plant-source omega-3 ALA were both linked to a risk reduction … with ALA showing a slight edge at a 43 percent cut, versus a 36 percent drop with high blood levels of seafood-source EPA and DHA.
Shanghai study links seafood to reduced diabetes risk
The new study involved 116,156 Chinese people – 51,963 men and 64,193 women – living in Shanghai. All were middle-aged and free of diabetes and cardiovascular disease at the outset of the six-year study.
The researchers visited the participants three times, at two-year intervals, to collect information about their diets and activity and to take physical measurements.
A subsequent data analysis by the U.S.-Chinese team linked higher seafood intake to a reduced risk of diabetes … and this beneficial association was stronger for women than for men.
Specifically, women’s diabetes risk was 11 to 14 percent lower among the one-fifth who reported the highest levels of fish and shellfish intake, respectively.
For men, those in the one-fifth who reported the highest shellfish intake were 16 percent less likely to develop diabetes within six years – with the risk dropping by 30 to 34 percent in the next two highest-intake groups.
The U.S.-Chinese team found no significant link between fish intake and diabetes risk in men from Shanghai.
Brostow DP, Odegaard AO, Koh WP, Duval S, Gross MD, Yuan JM, Pereira MA. Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2011 May 18. [Epub ahead of print] doi:10.3945/ajcn.110.009357
Djoussé L, Biggs ML, Lemaitre RN, King IB, Song X, Ix JH, Mukamal KJ, Siscovick DS, Mozaffarian D. Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr. 2011 May 18. [Epub ahead of print] doi:10.3945/ajcn.111.013334
Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003205. Review.
Hodge AM, English DR, O'Dea K, Sinclair AJ, Makrides M, Gibson RA, Giles GG. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr. 2007 Jul;86(1):189-97
Kaushik M, Mozaffarian D, Spiegelman D, Manson JE, Willett WC, Hu FB. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr. 2009 Sep;90(3):613-20. Epub 2009 Jul 22.
Odegaard AO, Koh WP, Butler LM, Duval S, Gross MD, Yu MC, Yuan JM, Pereira MA. Dietary patterns and incident type 2 diabetes in chinese men and women: the singapore chinese health study. Diabetes Care. 2011 Apr;34(4):880-5. Epub 2011 Feb 17.
Oliver E, McGillicuddy F, Phillips C, Toomey S, Roche HM. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA. Proc Nutr Soc. 2010 May;69(2):232-43. Epub 2010 Feb 17. Review.
Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H. The risk to develop NIDDM is related to the fatty acid composition of serum cholesterol esters. Diabetes 1994;43:1353-7.
Villegas R, Xiang YB, Elasy T, Li HL, Yang G, Cai H, Ye F, Gao YT, Shyr Y, Zheng W, Shu XO. Fish, shellfish, and long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in middle-aged Chinese men and women. Am J Clin Nutr. 2011 Jun 15. [Epub ahead of print]
Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2003;78:91-8.